In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp

Antimicrob Agents Chemother. 2010 Apr;54(4):1636-8. doi: 10.1128/AAC.01655-09. Epub 2010 Jan 19.

Abstract

The in vitro activities of eight antifungal drugs against clinical isolates of Fonsecaea pedrosoi (n = 21), Fonsecaea monophora (n = 25), and Fonsecaea nubica (n = 9) were tested. The resulting MIC(90)s for all strains (n = 55) were as follows, in increasing order: posaconazole, 0.063 microg/ml; itraconazole, 0.125 microg/ml; isavuconazole, 0.25 microg/ml; voriconazole, 0.5 microg/ml; amphotericin B, 2 microg/ml; caspofungin, 2 microg/ml; anidulafungin, 2 microg/ml; and fluconazole, 32 microg/ml.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amphotericin B / pharmacology
  • Anidulafungin
  • Antifungal Agents / pharmacology*
  • Ascomycota / drug effects*
  • Ascomycota / isolation & purification
  • Caspofungin
  • Chromoblastomycosis / drug therapy*
  • Chromoblastomycosis / microbiology*
  • Drug Resistance, Fungal
  • Echinocandins / pharmacology
  • Fluconazole / pharmacology
  • Humans
  • In Vitro Techniques
  • Itraconazole / pharmacology
  • Lipopeptides
  • Microbial Sensitivity Tests
  • Nitriles / pharmacology
  • Pyridines / pharmacology
  • Pyrimidines / pharmacology
  • Triazoles / pharmacology
  • Voriconazole

Substances

  • Antifungal Agents
  • Echinocandins
  • Lipopeptides
  • Nitriles
  • Pyridines
  • Pyrimidines
  • Triazoles
  • Itraconazole
  • isavuconazole
  • posaconazole
  • Amphotericin B
  • Fluconazole
  • Anidulafungin
  • Caspofungin
  • Voriconazole